Affordable Access

[Usefulness of GnRH agonists in preoperative treatment of complicated uterine myomata].

Authors
  • Campusano, C
  • Zapata, R
  • Bianchi, M
  • Badia, J I
  • Arteaga, E
Type
Published Article
Journal
Revista chilena de obstetricia y ginecología
Publication Date
Jan 01, 1993
Volume
58
Issue
2
Pages
150–154
Identifiers
PMID: 8209044
Source
Medline
License
Unknown

Abstract

The use of long acting gonadotropin-releasing hormone (Gn-RH) agonist produces a reversible hypogonadotropic hypogonadism. This effect has been used as presurgical treatment of uterine myomata, resulting in amenorrhea and reduction in uterus and tumour sizes. We describe the case of a 43 year old patient, having a uterine myoma associated with metrorrhagia, admitted to hospital because of extensive deep phlebothrombosis requiring urgent anticoagulation. Because of the risk of exacerbating metrorrhagia and considering the high morbidity associated to emergency hysterectomy, we decided medical treatment with a depot GnRH agonist (leuprolide acetate 3.75 mg IM monthly). Bleeding ceased within 3 days, allowing the maintenance of anticoagulant treatment. A marked reduction in uterine size postponed total hysterectomy to 3 months later. The characteristics of GnRH analogues, their action mechanisms, adverse effects and other clinical indications are discussed.

Report this publication

Statistics

Seen <100 times